What's new

Orphan designation: human decorin fused to the truncated homing peptide CRK Treatment of epidermolysis bullosa, 18/07/2022 Positive

Orphan designation: human decorin fused to the truncated homing peptide CRK Treatment of epidermolysis bullosa, 18/07/2022 Positive

Jun 5, 2025 - 15:00
 0
Orphan designation: human decorin fused to the truncated homing peptide CRK Treatment of epidermolysis bullosa, 18/07/2022 Positive
Orphan designation: human decorin fused to the truncated homing peptide CRK Treatment of epidermolysis bullosa, 18/07/2022 Positive
Read More

Tags:

Previous Article

Orphan designation: Resminostat Treatment of hepatocellular carcinoma, 27/09/201...

Next Article

Orphan designation: posnafusp alfa Treatment of mucopolysaccharidosis type IIIA ...

Related Posts

EMEA-003220-PIP01-22-M01

EMEA-003220-PIP01-22-M01

Jun 5, 2025  0

Human medicines European public assessment report (EPAR): Abrysvo, Respiratory syncytial virus vaccine (bivalent, recombinant), Date of authorisation: 23/08/2023, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR...

May 23, 2025  0

Human medicines European public assessment report (EPAR): Cinainu, dry aqueous extract of paullinia cupana seed,dry hydroethanolic extract of theobroma cacao seed,liquid ethanolic extract 30 per cent (W/W) of Allium cepa fresh bulb and Citrus limon fresh fruit, Status: Application withdrawn

Human medicines European public assessment report (EPAR...

May 26, 2025  0